Session: 222. Antimicrobial Stewardship: Potpourri Saturday, October 6, 2018: 12:30 PM Background. Urinary tract infections (UTIs) are among the most commonly treated infections in the Emergency Department (ED). Treatment is largely empiric and based on an institution-wide antibiogram comprised of isolates from all infection sites, which may overestimate antibiotic resistance of urinary pathogens of nonadmitted ED patients. The primary goal of this study was to determine the antibiotic susceptibilities of urinary pathogens isolated from adult patients with a UTI and discharged from the ED.
The most common organism isolated was Escherichia coli (164, 62%). E. coli urine isolates were most susceptible to nitrofurantoin (98%) followed by cefazolin (81%), ciprofloxacin (84%), and sulfamethoxazole/trimethoprim (64%). There was no difference in susceptibility rates of E. coli to cefazolin or sulfamethoxazole/trimethoprim, but isolates were more susceptible to ciprofloxacin in the ED compared with the institutional antibiogram (84% vs. 70%). Twenty-six (10.6%) patients grew an ESBL organism and of these, 42% (11/26) had no identifiable healthcare exposure within the last 90 days.
Conclusion. Despite limitations in sample size, this study supports using separate antibiograms and pathways for the treatment of UTI in the ED, especially in a community with high rates of local resistance to first-line agents.
Disclosures. Background. Hospital admissions due to acute decompensated heart failure (ADHF) are common, and the clinical presentation can be confused with other conditions such as pneumonia. Hospitalized ADHF patients often receive antibiotic therapy even when the clinical suspicion for pneumonia is low, and intravenous (IV) antibiotics are commonly used. We hypothesized the additional fluid and sodium content of potentially unnecessary antibiotic therapy could worsen outcomes and complicate management of ADHF patients.
Methods. We conducted a retrospective cohort analysis of adult patients with a diagnosis of ADHF. Patients were excluded if chest radiography suggested pneumonia, if they were continuing a prior antibiotic regimen, if they were diagnosed with a proven infection during admission, or if serum BNP level was not elevated. Patients who received antibiotics were compared with those who did not with respect to diuretic requirements, length of stay, sodium and fluid load attributable to antibiotic treatment, and readmission rate.
Results. Three hundred thirty-seven patients were screened for inclusion of which 153 were enrolled, 89 in the nonantibiotic arm compared with 64 in the antibiotic arm. Median length of stay in the antibiotic arm was 6.5 days as opposed to 3.25 days in the nonantibiotic arm (P < 0.001). The antibiotic group received a median dosage of 1,000 mg of furosemide compared with 400 mg in the nonantibiotic arm (P < 0.001). Patients who received antibiotics were 2.51 times more likely to be readmitted compared with patients who did not receive antibiotics (P = 0.04). On average, each patient in the antibiotic arm received approximately 970 mg of sodium daily and 1.6 L of volume attributed to antibiotic infusions.
Conclusion. Patients who received IV antibiotics during treatment for ADHF without evidence of infection had significantly longer lengths of stay, received significantly higher doses of furosemide, and were more likely to be readmitted compared with patients with the same diagnosis who were not exposed to intravenous antibiotics. Additional studies are needed to determine factors contributing to potential overprescribing in this population, and ADHF patients are a promising target of antibiotic stewardship interventions.
Disclosures. 
